AVTOZMA
NDC 72606-042, tocilizumab, injection, solution, from CELLTRION USA, Inc..
- Product NDC
- 72606-042
- Status
- Listed
- Labeler
- CELLTRION USA, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761420
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72606-042 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOCILIZUMAB80 mg/4mL
Pharmacologic classes
Interleukin 6 Receptor Antagonists [MoA]; Interleukin-6 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72606-042-01 | 72606004201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72606-042-01) / 4 mL in 1 VIAL, SINGLE-DOSE |
| 72606-042-02 | 72606004202 | 4 VIAL, SINGLE-DOSE in 1 CARTON (72606-042-02) / 4 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/581c288f-8015-40ef-a4c3-683c96db193dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=72606-042
Use it
Look up 72606-042 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72606-042 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72606-042. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.